|
Study | Sample size | Mean age (year) (median/range) | % men | Dose of radiotherapy (Gy) | CHE intervention | Control | Administration of CHE | Dose of CHE | Course of CHE (d) | Grading scale | Jadad score |
|
Bi and Sun 2015 | 50 | 58 | 60.0 | 40–65 | SFI | Placebo | iv | 40 mL | 42 d | RTOG | 4 |
Cong et al. 2012 | 50 | — | 82.0 | 60–70 | EI | — | iv | 400 mg | 14 d 2 cycles | RTOG | 4 |
Duan et al. 2014 | 63 | 60.2 | 74.6 | 60–66 | TRQI | — | iv | 20 mL | 30–33 d | RTOG | 4 |
Duan et al. 2014 | 96 | 46.2 | 53.1 | 40–76 | ADI | Glucocorticoid | iv | 50 mL | 20 d/40 d | RTOG | 4 |
Gong and Luo 2009 | 61 | 61.3 | 62.3 | — | TRQI + Antibiotics, Glucocorticoid | Antibiotics, Glucocorticoid | iv | 20 mL | 21 d | Reference | 4 |
Hou et al. 2013 | 232 | 60 | 78.0 | 30–70 | CKI | — | iv | 15–20 mL | 14 d 2 cycles | RTOG | 4 |
Huang et al. 2006 | 62 | 58.7 | 79.0 | — | SHLI + DXI | Antibiotics, Glucocorticoid | iv | 60 mg + 10–20 mL | 14 d | — | 4 |
Li and Ma 2015 | 50 | 56 | 66.0 | — | SQFZI + Antibiotics, Glucocorticoid | Antibiotics, Glucocorticoid | iv | 250 mL | 21 d | RTOG | 4 |
Li et al. 2016 | 120 | 54.36 | 60.0 | 50–66 | LI | — | iv | 100 mL | 35–45 d | Reference | 4 |
Li et al. 2014 | 98 | — | 59.2 | 50–64 | LI | — | iv | 80 mg | 33–42 d | RTOG | 4 |
Liu et al. 2013 | 130 | 54 | 56.2 | — | LBZI + Antibiotics, Glucocorticoid | Antibiotics, Glucocorticoid | iv | 200 mg | 21 d | Reference | 4 |
Liu and Li 2016 | 100 | 65.9 | 53.0 | 64–70 | LI | — | iv | 120 mg | 21 d | Reference | 4 |
Liu et al. 2008 | 85 | 65 | 70.6 | 60–70 | Berberine | Placebo | p.o. | 20 mg/kg | 42 d | RTOG | 7 |
Pan and Tang 2006 | 66 | 46.2 | 53.0 | 40–70 | SMI + Antibiotics, Glucocorticoid | Antibiotics, Glucocorticoid | iv | 50 mL | 7–14 d | RTOG | 4 |
Ruan and Qun 2010 | 40 | — | 35.0 | — | DI + Antibiotics, Glucocorticoid | Antibiotics, Glucocorticoid | iv | 800 mg | 21 d | Reference | 4 |
Tian et al. 2006 | 169 | 32–78 | 58.0 | — | TRQI | Antibiotics, Glucocorticoid | iv | 20 mL | 15 d | RTOG | 4 |
Xu 2013 | 72 | 55.7 | 54.2 | — | DLI + Antibiotics, Glucocorticoid | Antibiotics, Glucocorticoid | iv | 20 mL | 14 d | Reference | 4 |
Xu 2016 | 68 | 47.1 | 57.4 | — | XBJI + Antibiotics, Glucocorticoid | Antibiotics, Glucocorticoid | iv | 200 mL | 14 d | — | 4 |
Xu et al. 2013 | 85 | 45 | 56.5 | 38–70 | CKI | — | iv | 30 mL | 19–35 d | NCI-CTCAE | 4 |
Wang et al. 2013 | 224 | 60 | 79.9 | 60–70 | CKI | — | iv | 15 mL | 14 d | RTOG | 4 |
Wang et al. 2016 | 72 | 66 | 61.1 | 60–66 | YZXJC | — | p.o. | 4.68 g | 72–75 d | NCI-CTCAE | 4 |
Yan and Jiang 2014 | 80 | 57 | 76.3 | 60–65 | SMI | — | Aerosol inhalation | 20 mL | 35 d | RTOG | 4 |
Yang and Jia 2010 | 53 | 59.5 | 60.4 | 40–76 | SMI + Glucocorticoid | Glucocorticoid | iv | 30 mL | 28 d | UICC | 4 |
Yang et al. 2015 | 170 | 61.2 | 60.6 | 56–64 | TRQI | — | iv | 20 mL | 28 d | RTOG | 4 |
Zhang et al. 2007 | 104 | 56.9 | 55.8 | 39–65 | LBZI + Antibiotics, Glucocorticoid | Antibiotics, Glucocorticoid | iv | 400 mg | 21 d | Reference | 4 |
Zhang et al. 2012 | 126 | 57.6 | 68.3 | 60–72 | SMI | — | iv | 50 mL | With radiotherapy | RTOG | 4 |
Zheng et al. 2007 | 80 | 61.3 | 66.3 | 40–60 | SQFZI + Antibiotics, Glucocorticoid | Antibiotic, Glucocorticoid | iv | 250 mL | 14 d | RTOG | 4 |
Zou and Liu 2008 | 128 | 55 | 51.6 | — | LBZI + Antibiotics, Glucocorticoid | Antibiotics, Glucocorticoid | iv | 400 mg | 21 d | Reference | 4 |
|